Healthcare & Pharma
Healthcare and Pharma firms are the most analysed and evaluated organisations in business today
With increasing operating and marketing costs, industry-specific concerns include thinning drug pipelines, growing generic competition, and drug affordability, organisations require a clear view of marketing conditions, brand penetration and dimensions like Prescribers, KOLs, Payers and PBMs, Patients, Network pharmacies and Promotions & Discounts.
This clarity depends on modern technologies and big data to consider factors like clinical trials and their results, market potential, intensity of competition, patient persistency, physician references, discount provisions, contracting strategies with insurance providers, till drug dispense and eventual sales.
Just A Few Of The Problems We Have Solved Include
How should we design an efficient call planning & physician targeting strategy to improve brand propensity?
What is the impact on brand performance when patients switch to competing drugs? What corrective measures can ensure patients do not churn out?
What is the impact of changing formulary (tiers & restrictions) access over drug approvals/rejections and physician’s prescribing behavior?
What factors should be considered to forecast drug sales and build a scalable time series framework?
How should the PBM portfolio be optimized to target and design better healthcare coverage strategies with the bigger players in insurance?
What are the different steps that occur in a patient’s journey from disease discovery to drug subscription?